- CHANHO H. PARK, M.D., Medical Director >>
- KEVIN L. COOPER, M.D. >>
Medical Director
Dr. Chanho Park is the Medical Director for Predictive Biosciences’ Cleveland Laboratory. He previously served as the Medical Director for the Department of Laboratory Medicine at the St. Vincent Charity Hospital in Cleveland, Ohio. Prior to Predictive Biosciences’ acquisition of OncoDiagnostic Laboratory (ODL), Chanho led the pathology group as Medical Director and Managing Partner. At ODL he developed a new image cytometry methodology for tissue sections to quantitate the DNA content in cancer cells.
Chanho taught GI pathology to medical students as an Assistant Professor at Case Western Reserve University School of Medicine and member of their GI committee. He established the immunohistochemistry laboratory at MetroHealth Medical Center in Cleveland, Ohio, where he completed his pathology residency.
Chanho has authored many publications in general surgical pathology with a main focus in gastrointestinal/liver pathology, urology and immunohistochemistry and presented papers and conducted seminars for the International Academy of Pathology. He received his medical degree from the College of Medicine at Seoul National University and is board certified in anatomic and clinical pathology.
Dr. Cooper is a Pathologist at Predictive Biosciences and is the Chairman of Pathology and Laboratory Medicine, and the Cancer Liaison Physician for the cancer program at St. Vincent Charity Hospital in Cleveland, Ohio. Kevin previously served as Director of Pathology and Laboratory Medicine at Wadsworth-Rittman Hospital.
Kevin completed his residency in anatomic and clinical pathology at the Cleveland Clinic Foundation and MetroHealth Medical Center (previously Cleveland Metropolitan General Hospital). He received his medical degree from Ohio State University and is board certified in anatomic and clinical pathology.
